Cancer researchers at Intermountain Healthcare are launching a three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
There are numerous projects underway on the NJIT campus that focus on, or have a significant component of, cybersecurity. Here's a look at 7 NJIT research initiatives that take a bite out of cybercrime.
John Wiley and Sons Inc. (NYSE:JWa) (NYSE:JWb) is delighted to announce its selection by the American Fisheries Society (AFS) as publishing partner for its prestigious journals and magazine devoted to the research of aquatic sciences and fisheries resources.
IIVS, supported by a grant from Colgate-Palmolive, held a training course this month in Goiania, Brazil focused on two in vitro methods with international regulatory acceptance status. The course, Alternative Methods for Evaluation of Toxicity, was attended by over 30 participants from industry and government who participated in both lectures and hands-on exercises. The training course was organized as a satellite workshop to the Congress of Brazilian Toxicology, CBTox, in Goias, Brazil.
PharmaMar (MSE:PHM) will present the final efficacy and safety data obtained from the Phase I/II trial combining PM1183 (lurbinectedin).
A new study from the US Department of Energy's National Renewable Energy Laboratory quantifies how much charging infrastructure would be needed in the United States to support various market growth scenarios for plug-in electric vehicles.
Surgeons at Penn Medicine are using a fluorescent dye that makes cancerous cells glow in hopes of identifying suspicious lymph nodes during head and neck cancer procedures. Led by Jason G. Newman, MD, FACS, an associate professor of Otorhinolaryngology in the Perelman School of Medicine at the University of Pennsylvania, the study is the first in the world to look at the effectiveness of intraoperative molecular imaging (IMI) of lymph nodes in patients with head and neck cancer.
At its autumn session, the Senate of the Deutsche Forschungsgemeinschaft approved the establishment of two new Senate Commissions.
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted 'Investigative New Drug' status by the US Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
Leica Microsystems and ICFO sign an R&D collaboration agreement to establish ICFO as a Nanoscopy Imaging Reference Site for Leica and to push the frontiers of science in the field of super-resolution microscopy and nanoscopy. The Nanoscopy Imaging Reference Site will allow advancement in the study of diseases such as Leukemia, Alzheimer or retinal degeneration, among others. With the new super-resolution Leica microscope, ICFO's SLN facility will be completely adaptable to the specific needs of researchers from research institutions across Europe.